Leaky gut in treated HIV: scientists probe why immune repair fails
NCT ID NCT02906137
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study investigates why the gut immune barrier remains damaged in people with HIV even after successful antiretroviral therapy. Researchers collected blood and intestinal biopsies from 80 participants to measure immune cells and inflammation. The goal is to understand why the gut doesn't fully recover, which could help reduce long-term health problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could point toward new ways to help the gut immune system recover in people living with HIV, potentially reducing long-term inflammation.
What could go wrong
This is an observational study, not a treatment trial. It aims to understand the problem, not test a solution. Results may not lead directly to new therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Purpan - Service de Médecine Interne
Toulouse, 31059, France
-
Hôpital Purpan - Service des maladies Infectieuses
Toulouse, 31059, France